Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
ORIGINAL ARTICLE
Fluoxetine does not influence response to continuous theta burst stimulation in human motor cortex
- First Published: 07 November 2024
The association between benzodiazepine prescriptions and the risk of laxative use in schizophrenia treatment
- First Published: 07 November 2024

The results of univariate and multivariate logistic regression analyses in the laxative and non-laxative groups are shown in graphical abstract. The results of multivariate logistic regression analyses revealed that benzodiazepine prescriptions were significantly higher in the laxative group (OR, 3.059; 95% CI, 1.523–6.144; p = 2.0 × 10−3).
CASE REPORT
Development of cefepime-induced encephalopathy in a patient with depression and rectal cancer: A case report
- First Published: 13 November 2024
ORIGINAL ARTICLE
Orexin concentrations and diurnal variation in the cerebrospinal fluid of intensive care unit patients undergoing aortic surgery with spinal drainage
- First Published: 14 November 2024
NSW cannabis medicines advisory service retrospective enquiry analysis to inform clinical guidance resource development
- First Published: 17 November 2024

This analysis of enquiries to a comprehensive state government funded cannabis medicines advisory service provides complementary real-world data to clinical trials. Advisory service data adds to existing observational data related to patient clinical characteristics, cannabinoid selection, and potential comorbid disease- and drug-interactions. The findings of this study shed light on the information medical practitioners were seeking to inform their clinical decision making about medical cannabis and informed the development of clinical guidance resources.
Initial psychotropic prescriptions and symptom associations in first-visit patients with major depressive disorder: A single-center cross-sectional study
- First Published: 20 November 2024

Among the first-visit patients, 31.4% (118/376) were prescribed antidepressants. Missing educational attainment data and the view of myself domain of the QIDS-J were negatively associated, while the concentration/decision making domain of the QIDS-J was positively associated with antidepressant initiation.
GUIDELINES
Guideline for pharmacological treatment of schizophrenia 2022
- First Published: 25 November 2024
ORIGINAL ARTICLE
Current status and features of antipsychotic prescriptions in Japanese forensic psychiatric wards based on a forensic inpatient database
- First Published: 26 November 2024

We analyzed the current status of antipsychotics for Japanese forensic inpatients with schizophrenia spectrum disorders nationwide. Olanzapine was the most commonly prescribed antipsychotic, followed by clozapine. Clozapine was associated with longer hospitalization and a higher rate of seclusion experience.
MICRO REPORT
Inhibitory effects of the selective μ-opioid receptor antagonist UD-030 on methamphetamine-induced conditioned place preference
- First Published: 27 November 2024

Although methamphetamine (METH) and other addictive substance use disorders are a major social problem worldwide, appropriate pharmacotherapies have not yet been discovered. The novel nonpeptidic μ-opioid receptor (MOP)-selective antagonist UD-030 dose-dependently inhibited the acquisition and expression of METH-induced conditioned place preference (CPP) in mice. These results indicate that UD-030 may effectively inhibit rewarding effects of METH and suggest that a novel MOP-selective antagonist may be a candidate for the development of pharmacotherapies for METH addiction.
ORIGINAL ARTICLE
Dysregulated HPA axis during postnatal developmental stages in the BTBR T+ Itpr3tf/J mouse: A model of autism spectrum disorder
- First Published: 28 November 2024

During postnatal development, both BTBR T+ Itpr3tf/J (BTBR) mice, a model of autism spectrum disorder (ASD), and control C57BL/6J mice exhibited characteristic changes in basal corticosterone levels, peaking at weaning. At weaning, BTBR mice showed dysregulated stress responses characterized by higher corticosterone and corticotropin-releasing hormone levels but lower adrenocorticotropic hormone levels after acute stress exposure. Additionally, BTBR mice displayed altered expression of glucocorticoid receptor mRNA in specific brain regions, suggesting disrupted hypothalamic–pituitary–adrenal axis function at weaning in this ASD model.
Characteristics of psychiatric patients with nightmares after suvorexant administration: A retrospective study
- First Published: 29 November 2024

This study investigates the risk factors for nightmares among psychiatric patients treated with suvorexant, an orexin receptor antagonist. A retrospective analysis of 440 patients revealed that 9.1% experienced nightmares, with younger patients (aged 20–39 years) being at a significantly higher risk. These findings suggest age-dependent susceptibility to suvorexant-induced nightmares, highlighting the importance of caution when prescribing this medication to younger individuals.
MICRO REPORT
Effects of 3,4-methylenedioxymethamphetamine on neural activity in the nucleus accumbens of male mice engaged in social behavior
- First Published: 03 December 2024

In this study, fiber photometry recordings revealed transient increase in neural activity of the nucleus accumbens (NAc) at the onset of turning toward and sniffing novel mice during the social approach test. 3,4-methylenedioxymethamphetamine (MDMA) administration did not alter NAc neural activity during these social behaviors, whereas it increased social approach time.
ORIGINAL ARTICLE
Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms
- First Published: 04 December 2024

Subjects with insomnia disorder treated for mild depression or anxiety symptoms from E2006-G000-303, a 12-month, phase 3, randomized, placebo-controlled, double-blind study where subjects were randomized (1:1:1) to placebo, lemborexant 5 mg, or lemborexant 10 mg for 6 months, were evaluated. Lemborexant treatment had a positive effect on sleep in subjects with insomnia disorder treated with medications for depression/anxiety symptoms, with no new safety signals.
Effects of short-term exposure to moderate amounts of alcohol on brain volume
- First Published: 12 December 2024

This study reveals short-term brain changes from moderate alcohol doses in healthy volunteers. MRI scans show an increase in lateral ventricular volumes and a decrease in specific gray matter regions. These changes suggest acute alterations in CSF dynamics and brain water content, highlighting the need for further research into the underlying biological mechanisms.
Association Between Stress-Induced Weight Loss and Autophagy-Related Gene Expression in the Hippocampus and Midbrain of Depression Model Mice
- First Published: 23 December 2024

This study examined the effects of chronic immobilization stress (CIS) on mouse behavior, weight, and autophagy-related gene expression in the hippocampus. In the CIS response group, a correlation analysis was conducted between weight change ratio and Fkbp5 mRNA expression levels, using Pearson's correlation coefficient. Results showed a significant correlation, with significance defined at a p value< 0.05.
CORRECTION
MICRO REPORT
Administration of a Selective Antagonist for Pituitary Adenylate Cyclase-Activating Polypeptide Receptor in the Hippocampus Causes Anxiolytic Effects in the Male Rat
- First Published: 26 December 2024

PACAP-6-38, a PAC1R-selective antagonist, was injected into the hippocampus of Sprague–Dawley rats to assess its effect on anxiety-like behavior. The results showed that the drug led to increased time spent in the open arm of the elevated plus-maze, indicating an anxiolytic effect. This suggests that hippocampal PACAP may play a role in promoting anxiety-like behavior.
ORIGINAL ARTICLE
Association between psychological distress and schizotypy in adults: A cross-sectional study
- First Published: 27 December 2024
MICRO REPORT
Population Using Tobacco for Pain Relief: A Preliminary Cross-Sectional Study in Japan
- First Published: 02 January 2025

This research reports the results of a preliminary cross-sectional study on tobacco use for pain relief in Japan. The survey found that 6.6% of smokers experiencing pain (8.8% in cases of chronic pain) used tobacco for pain relief. Those who used tobacco for pain relief tended to be younger, more likely to be receiving treatment for schizophrenia and pain, had higher rates of analgesic use, and reported greater pain intensity and catastrophic thinking about pain.
ORIGINAL ARTICLE
Biotin Mitigates Alcohol Withdrawal-Induced Anxiety and Depression by Regulating Serotonin Metabolism, BDNF, Inflammation, and Oxidative Stress in Rats
- First Published: 04 January 2025

Biotin has been shown to alleviate anxiety and depression associated with alcohol withdrawal in rats by regulating serotonin metabolism and brain-derived neurotrophic factor levels and reducing inflammation and oxidative stress. This suggests that biotin could serve as a potential therapeutic agent for managing withdrawal symptoms in substance use disorders.
REVIEW ARTICLE
Neurobiology of COVID-19-Associated Psychosis/Schizophrenia: Implication of Epidermal Growth Factor Receptor Signaling
- First Published: 04 January 2025
Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus
- First Published: 05 January 2025

This review examines the role of activated platelets in Alzheimer disease (AD) pathology, highlighting their contribution to amyloid peptide (Aβ) accumulation and neurofibrillary tangles. While platelets normally support neuronal health and synaptic plasticity, their overactivation may exacerbate AD. Targeting activated platelets presents a potential strategy to mitigate AD neuropathology.
ORIGINAL ARTICLE
Gender Differences in the Effects of Trust on Substance Abuse Severity Among Incarcerated Stimulant Offenders in Japan
- First Published: 08 January 2025

This study clarified gender differences in the effect of trust on the severity of drug dependence, using data from stimulant offenders imprisoned throughout Japan. Our findings indicate that men's sense of trust in oneself negatively influenced the drug dependence severity; on the other hand, women's distrust in others positively affects the severity of their drug dependence. Thus, it is necessary to consider gender differences when support is provided for stimulant offenders.
Nicotine dependence based on the tobacco dependence screener among heated tobacco products users in Japan, 2022–2023: The JASTIS study
- First Published: 09 January 2025
MICRO REPORT
Co-Expression of Tardive Dyskinesia and Drug-Induced Parkinsonism in Rats Chronically Treated With Haloperidol
- First Published: 09 January 2025

Rats chronically treated with haloperidol exhibit drug-induced parkinsonism and tardive dyskinesia. Expression of dynorphin, enkephalin, and dopamine D1 and D2 receptors was altered in haloperidol-treated rats. Both indirect and direct pathways are involved in haloperidol-induced movement disorders.
REVIEW ARTICLE
Residual Fatigue in Unipolar and Bipolar Depression: A Systematic Review
- First Published: 09 January 2025
MICRO REPORT
Reliability and Validity of the Japanese Version of the Internet Gaming Disorder Scale for Children (IGDS-C)
- First Published: 10 January 2025
ORIGINAL ARTICLE
The Association Between Autism Spectrum Disorders and Dietary Intake of Carbohydrates in School-Aged Children in Iran: A Case–Control Study
- First Published: 21 January 2025
CASE REPORT
Successful Clozapine Treatment for Treatment-Resistant Schizophrenia With Zinc Deficiency Severe Anemia: A Case Report
- First Published: 21 January 2025
REVIEW ARTICLE
Metformin and Cognitive Performance in Patients With Type 2 Diabetes: An Umbrella Review
- First Published: 27 January 2025

Even though metformin shows promise in improving specific cognitive domains, such as memory, and reducing neurodegenerative risks, its effects remain inconsistent across different cognitive assessments. The low quality of existing evidence highlights the need for robust research to determine whether metformin's cognitive impacts are protective, neutral, or dependent on individual patient profiles.
ORIGINAL ARTICLE
Association Analysis of Rare CNTN5 Variants With Autism Spectrum Disorder in a Japanese Population
- First Published: 30 January 2025

We investigated the role of rare CNTN5 variants in ASD susceptibility by performing resequencing, genotyping, and association analysis in a Japanese population. Out of three identified CNTN5 rare putatively damaging variants, we found a nominally significant association between the I227 variant and ASD in 614 patients with ASD and 61 058 healthy controls, but not after post hoc correction. Hyperacusis was noted in three out of nine patients carrying the variants.
Effects of Psychotropic Medications Taken by Pregnant Women on Newborn Medical Condition and Lactation Method
- First Published: 30 January 2025
Effectiveness of Attentional Bias Modification Combined With Cognitive Behavioral Therapy in Reducing Relapse Risk and Cravings in Male Patients With Alcohol Use Disorder: A Quasi-Randomized Controlled Trial
- First Published: 05 February 2025

This quasi-randomized controlled trial investigated a novel combined approach of attention bias modification (ABM) with cognitive behavioral therapy (CBT) for male inpatients with alcohol use disorder (AUD). Both the CBT + ABM intervention and CBT-alone groups showed substantial improvements in relapse risk and craving levels over the 6-week treatment period, demonstrating the therapeutic potential of integrating attention retraining with conventional treatment. These findings support the viability of both treatment approaches while suggesting opportunities for future research to optimize combined interventions in naturalistic settings.
Gene Expression Signatures of Immaturity, Decreased pH, and Neural Hyperexcitation in the Hippocampus of Alzheimer's Disease Model Mice
- First Published: 05 February 2025

Analyses of the 20 gene expression datasets of hippocampus of Alzheimer's disease model mice revealed patterns linked to immaturity, decreased pH, and neural hyperexcitation. Pathway analysis suggests that the gene expression changes might be involved in synaptic and channel functions, as well as inflammatory responses.
Gene Expression Profiling in the Cortex of Fabp4 Knockout Mice
- First Published: 08 February 2025

This study investigates the role of Fabp4 in brain function using Fabp4 knockout (KO) mice. Despite negligible Fabp4 expression in the brain, RNA-seq analysis revealed significant changes in genes associated with synaptic organization and epigenetic regulation. These findings support the concept of an “adipo-brain axis,” where peripheral metabolic processes influence neural function and behavior.
MICRO REPORT
Usefulness of the WAIS-IV Short Form for Measuring Cognitive Function in Patients With Schizophrenia
- First Published: 12 February 2025
ORIGINAL ARTICLE
A Longitudinal Study of the Association of Blood Unsaturated Fatty Acids With Posttraumatic Stress Disorder (PTSD)
- First Published: 17 February 2025
REVIEW ARTICLE
Efficacy of Pharmacological Interventions in Milder Depression: A Systematic Review and Meta-Analysis
- First Published: 27 February 2025

This systematic review examined pharmacological interventions for mild depression; however, no trials were identified that specifically compared antidepressants with placebo exclusively in patients with mild depression. Among supplements, eicosapentaenoic acid and Rhodiola rosea emerged as potential treatment options. The scarcity of high-quality studies highlights the need for further rigorous research to inform evidence-based treatment strategies.
CASE REPORT
A Report of Three Cases With Dissociative Disorder: Some Positive Response to Methylphenidate Extended Release Used for Their Concurrent Attention Deficit Hyperactivity Disorder
- First Published: 21 February 2025
ORIGINAL ARTICLE
Comparison of Efficacies of a Blonanserin Transdermal Patch and Blonanserin Oral Formulation for Psychiatric Symptoms in Patients With Schizophrenia Treated With Laxatives Using a Japanese Claims Database
- First Published: 21 February 2025

Laxative use has recently been identified as a risk factor for hospitalization in patients with schizophrenia, and oral antipsychotic medication may be problematic due to gastrointestinal dysfunction affecting absorption, suggesting that transdermal antipsychotic patches could be a suitable alternative. A retrospective cohort study compared the efficacies of a blonanserin (BNS) patch and BNS oral formulation in patients with schizophrenia treated with laxatives, with the primary outcome being hospitalization to psychiatric wards. The study found no significant difference in the risk of hospitalization between the BNS patch and BNS oral groups, and further research is warranted to consider factors such as patch preference in the elderly.
Epigenetic Clock Analysis for National Institutes of Health Stroke Scale in Patients With Ischemic Stroke
- First Published: 22 February 2025

We conducted epigenetic clock analyses to investigate the association between the difference in NIHSS (dNIHSS) and multiple epigenetic aging in patients with ischemic stroke. There was no significant association in the epigenetic age acceleration. We may be able to find different findings with larger sample size, and longitudinal data such as NIHSS scores at fixed intervals.
Proposal for a Novel Classification of Patients With Enlarged Ventricles and Cognitive Impairment Based on Data-Driven Analysis of Neuroimaging Results in Patients With Psychiatric Disorders
- First Published: 26 February 2025
The Impact of Anhedonia on the Disease Burden of Major Depressive Disorder in the Asia–Pacific Region: A Cross-Sectional Real-World Study
- First Published: 26 February 2025

This cross-sectional, web-based survey study was conducted across Australia, China Mainland, Japan, Malaysia, South Korea, and Taiwan, to assess the impact of anhedonia on the health-related quality of life (HRQoL), health-care resource utilization (HRU), and work productivity in subjects with major depressive disorder (MDD). Multivariate analysis revealed that MDD subjects with anhedonia had significantly worse sexual functioning HRQoL as well as higher HRU and impairment to work productivity and activity than subjects without anhedonia.
CASE REPORT
Unwanted Clinical Complications Following the Consumption of Death Coffee: A Case Series
- First Published: 17 March 2025
ORIGINAL ARTICLE
Associations Between Cognitive Impairment, Depressive Symptoms, and Work Productivity Loss in Patients With Bipolar Disorder: A Cross-Sectional Analysis
- First Published: 20 March 2025

This interim, cross-sectional analysis to evaluate the relationship between cognitive impairment and work productivity loss in patients with bipolar disorder examined correlations among baseline symptom scores and correlations between each symptom score and work productivity loss (presenteeism) and quality of life. Cognitive impairment, depression, and insomnia were associated with both presenteeism and quality of life. The study findings suggest that treatment should focus on improving the core symptoms of bipolar disorder as well as insomnia and cognitive impairment.